Dr. Foluso A. Fakorede, MD

Dr. Fakorede practices at Bolivar Medical Center in Cleveland, Mississippi, part of Lifepoint Health.

Dr. Fakorede's NPI, 1679730329, was assigned on May 20, 2008. Dr. Fakorede graduated from Rutgers R W Johnson Medical School (Cam/New Bruns/Pisc) in 2006. Dr. Fakorede holds Mississippi license 23725.

Dr. Fakorede's primary practice is Bolivar Medical Center, at 901 E Sunflower Rd, Cleveland, MS 38732 in Bolivar County. The practice phone is (662) 846-0061.

Dr. Fakorede's primary practice is Bolivar Medical Center in Cleveland, Mississippi, part of Lifepoint Health. Dr. Fakorede is also affiliated with Delta Health System - The Medical Center. The medical group on file is Cardiovascular Solutions of Central Mississippi. Dmand AI also links Dr. Fakorede to 1 more hospital, 1 physician office, 1 group practice or clinic and 1 skilled nursing facility, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fakorede practices, 6 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Fakorede's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Fakorede is licensed in Mississippi.

CMS data shows 9,738 Medicare services from Dr. Fakorede across 33 procedure codes in 2024, for 497 Medicare patients. Medicare paid $1,148,735 for them. Every service was in an office.

CMS counts 497 Medicare patients who saw Dr. Fakorede in 2024. The largest group is 65 to 74, with 208 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 45% are also on Medicaid. Their average risk score is 1.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Fakorede's median patient age at 70, with 61% women.

In 2024, Dr. Fakorede wrote 8,967 Medicare Part D claims for 1,197 patients. 79% of them were for generic drugs. CMS names the drug for 8,770 of them, across 55 drugs with 11 or more claims each, at $1,407,138 in total drug cost. In 2023, CMS named 12,468 claims across 59 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Fakorede for performance year 2024, reported individually. Dr. Fakorede accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 112 procedures of leg revascularization (restoring blood flow) by Dr. Fakorede, more than 98% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Fakorede, published from 2021 to 2025. 2022 was the busiest year, with 2. The most frequent topics are Amputation, Surgical, Black or African American and Healthcare Disparities. Dr. Fakorede's most frequent co-authors are Olamide Alabi, MD, Sophia Elissa Altin, MD and Wayne B. Batchelor, MD.

CMS Open Payments shows 1,165 general payments to Dr. Fakorede from 49 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 34% of the total. Abbott Laboratories paid the most, $118,603.

Dr. Fakorede graduated from Rutgers R W Johnson Medical School (Cam/New Bruns/Pisc) in 2006.